Arcellx (ACLX) Current Assets (2021 - 2025)
Arcellx's (ACLX) quarterly Current Assets came in at $462.2 million in Q4 2025, down 22.88% year-on-year from $599.3 million in Q4 2024, and down 2.1% quarter-over-quarter from $472.1 million in Q3 2025.
Arcellx (ACLX) Current Assets (2021 - 2025) Analysis & Trends
Arcellx's Current Assets history runs 5 years deep, the most recent figure standing at $462.2 million for Q4 2025.
- On a quarterly basis, Current Assets fell 22.88% year-over-year to $462.2 million in Q4 2025; TTM through Dec 2025 was $462.2 million, a 22.88% decrease from a year earlier, with the FY2025 full-year figure at $462.2 million, down 22.88% from the prior year.
- Current Assets eased to $462.2 million in Q4 2025 per ACLX's latest filing, from $472.1 million in the prior quarter.
- Across five years, Current Assets topped out at $716.4 million in Q4 2023 and bottomed at $112.8 million in Q4 2021.
- The 5-year median for Current Assets is $491.5 million (2023), against an average of $459.7 million.
- Across the five-year window, Current Assets jumped 168.44% in 2023 and dropped 22.88% in 2025, its largest moves.
- Year by year, Current Assets stood at $112.8 million in 2021, then surged by 136.56% to $266.9 million in 2022, then soared by 168.44% to $716.4 million in 2023, then fell by 16.34% to $599.3 million in 2024, then fell by 22.88% to $462.2 million in 2025.
- Per Business Quant, the three latest ACLX Current Assets figures stand at $462.2 million (Q4 2025), $472.1 million (Q3 2025), and $463.9 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 462.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 462.18 Mn |
| Sep 30, 2025 | 472.08 Mn |
| Jun 30, 2025 | 463.90 Mn |
| Mar 31, 2025 | 554.15 Mn |
| Dec 31, 2024 | 599.31 Mn |
| Sep 30, 2024 | 587.30 Mn |
| Jun 30, 2024 | 530.20 Mn |
| Mar 31, 2024 | 588.73 Mn |
| Dec 31, 2023 | 716.36 Mn |
| Sep 30, 2023 | 491.46 Mn |
| Jun 30, 2023 | 558.07 Mn |
| Mar 31, 2023 | 571.37 Mn |
| Dec 31, 2022 | 266.86 Mn |
| Sep 30, 2022 | 290.31 Mn |
| Jun 30, 2022 | 325.08 Mn |
| Mar 31, 2022 | 224.39 Mn |
| Dec 31, 2021 | 112.81 Mn |